Hikma Pharmaceuticals

Xellia Pharmaceuticals ApS is a specialty pharmaceutical company headquartered in Copenhagen, Denmark, focused on developing, manufacturing, and supplying anti-infective products for the global market. Established in 1959, the company specializes in both fermented and semi-synthetic active pharmaceutical ingredients (APIs) and finished dosage forms (FDF). Xellia is recognized as a leading supplier of Vancomycin and Colistimethate Sodium, providing clinically effective treatments for serious bacterial and antibiotic-resistant infections as well as certain fungal diseases. The company operates four manufacturing facilities in Hungary, China, and the United States, adhering to current Good Manufacturing Practice (cGMP) standards and regulatory approvals from authorities such as the US Food and Drug Administration. Xellia also offers a range of contract manufacturing services, including custom synthesis for clinical trials and large-scale production, while continually expanding its product range to address evolving treatment needs. With over 850 employees, Xellia serves more than 700 customers across over 70 countries.

Rakuten Medical, Inc. is a clinical-stage biotechnology company focused on developing precision-targeted therapies for cancer treatment. The company is known for its investigational therapies based on the proprietary Alluminox platform, which includes drugs, devices, and other components designed for cell targeting. Notably, Rakuten Medical is developing ASP-1929, an antibody-drug conjugate that combines cetuximab with IRDye 700DX, along with RM-1929 and photoimmunotherapy specifically for head and neck cancer. Founded in 2010 and headquartered in San Mateo, California, Rakuten Medical has expanded its presence with offices in the United States, Japan, Taiwan, the Netherlands, and Germany.

CUSTOpharm is a service-oriented company specializing in the development and manufacturing of complex sterile injectable generic products. The company focuses on providing personalized and cost-effective chemistry and manufacturing controls (CMC) and regulatory support to clients with limited resources or those looking to expand. CUSTOpharm has developed a diverse portfolio of 54 sterile products, including 48 injectable, 2 nasal, 2 oral, and 2 sterile ophthalmic products. With extensive experience in sourcing difficult-to-obtain raw materials, addressing formulation and analytical challenges, and managing regulatory submissions, CUSTOpharm has filed over 170 Abbreviated New Drug Applications (ANDAs) since becoming the first to submit an electronic Common Technical Document (eCTD) ANDA to the FDA in 2004. This comprehensive approach enables CUSTOpharm to align its efforts with the overarching goals of its clients, ensuring the delivery of market-ready products.

EIMC United Pharma, a pharmaceutical manufacturing company, specializes in manufacturing oncology generics.

Roxane Laboratories, Inc. is a specialty generics company based in Columbus, Ohio, founded in 1885. The company focuses on the research, development, manufacture, marketing, sale, and distribution of generic pharmaceuticals in the United States. Roxane Laboratories offers a diverse portfolio of 111 products across seven dosage forms, including immediate-release solids, nasal sprays, liquids, and sublingual tablets. Key marketed products include fluticasone, buprenorphine, methotrexate, prednisone, and calcium acetate. Additionally, the company has a robust pipeline of approximately 90 products in various stages of development and also manufactures branded pharmaceutical products. Roxane Laboratories distributes its offerings to wholesalers, retail chain pharmacies, and group purchasing organizations, and has operated as a subsidiary of Eurohealth (U.S.A.), Inc. since 2016.

Bedford Laboratories engages in the manufacture and distribution of generic injectables.

Egyptian Company for Pharmaceuticals & Chemical Industries manufacture pharmaceutical products. The company’s products include cephalosporin anti–infective medicines.

Promopharm SA is an industrial pharmaceutical company that specializes in the production, marketing, import, and export of a wide range of products, including pharmaceuticals, parapharmaceuticals, dermopharmaceuticals, and cosmetics. The company is dedicated to offering a diverse portfolio of pharmaceutical specialties and is actively involved in both domestic and international markets. Through its operations, Promopharm aims to meet the needs of consumers and healthcare professionals by providing high-quality products in the pharmaceutical and cosmetic sectors.

Unimark Remedies is a healthcare company specializing in the development and manufacture of generic medicines across multiple therapeutic segments, including respiratory, cardiovascular, anti-infective, and central nervous system treatments. The company aims to provide affordable generic formulations to clients and customers worldwide, establishing a notable presence in the global market. In addition to its core pharmaceutical offerings, Unimark Remedies also supplies a range of healthcare products, including diagnostics, medical devices, finished formulations, cosmeceuticals, animal healthcare products, and active pharmaceutical ingredients. Through its diverse portfolio, Unimark Remedies seeks to meet various healthcare needs while maintaining a commitment to quality and accessibility.

The Arab Pharmaceutical Manufacturing Co. Ltd. manufactures pharmaceutical products.

Alkan Pharma is develops and manufactures generic pharmaceuticals in both solid and liquid forms.

Thymoorgan Pharmazie GmbH produces thymus extracts and various organ extracts; and manufactures liquid and freeze-dried parenterals.

Jazeera Pharmaceuticals Industries is engages in the research, development, manufacture, and marketing of pharmaceutical products. It provides pharmaceutical products in tablet, syrup, and cream forms for applications in musculoskeletal, anti-infective, cardiovascular, CNS, respiratory, dermatology, alimentary, and genito-urinary therapeutic areas.